Kim YC - Search Results

1

Plasmid DNA Nanoparticles for Nonviral Oral Gene Therapy.

Shahriar SMS, An JM, Hasan MN, Surwase SS, Kim YC, Lee DY, Cho S, Lee YK. Shahriar SMS, et al. Among authors: kim yc. Nano Lett. 2021 Jun 9;21(11):4666-4675. doi: 10.1021/acs.nanolett.1c00832. Epub 2021 May 24. Nano Lett. 2021. PMID: 34029475

2

Oral Gavage Delivery of PR8 Antigen with β-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity.

Lee DY, Nurunnabi M, Kang SH, Nafiujjaman M, Huh KM, Lee YK, Kim YC. Lee DY, et al. Among authors: kim yc. Biomacromolecules. 2017 Apr 10;18(4):1172-1179. doi: 10.1021/acs.biomac.6b01855. Epub 2017 Mar 21. Biomacromolecules. 2017. PMID: 28278374

3

Self-gelling electroactive hydrogels based on chitosan-aniline oligomers/agarose for neural tissue engineering with on-demand drug release.

Bagheri B, Zarrintaj P, Surwase SS, Baheiraei N, Saeb MR, Mozafari M, Kim YC, Park OO. Bagheri B, et al. Among authors: kim yc. Colloids Surf B Biointerfaces. 2019 Dec 1;184:110549. doi: 10.1016/j.colsurfb.2019.110549. Epub 2019 Oct 4. Colloids Surf B Biointerfaces. 2019. PMID: 31610417

4

Engineered Nanoparticles inside a Microparticle Oral System for Enhanced Mucosal and Systemic Immunity.

Surwase SS, Shahriar SMS, An JM, Ha J, Mirzaaghasi A, Bagheri B, Park JH, Lee YK, Kim YC. Surwase SS, et al. Among authors: kim yc. ACS Appl Mater Interfaces. 2022 Mar 9;14(9):11124-11143. doi: 10.1021/acsami.1c24982. Epub 2022 Feb 28. ACS Appl Mater Interfaces. 2022. PMID: 35227057

5

Carbon-based nanostructures for cancer therapy and drug delivery applications.

Bagheri B, Surwase SS, Lee SS, Park H, Faraji Rad Z, Trevaskis NL, Kim YC. Bagheri B, et al. Among authors: kim yc. J Mater Chem B. 2022 Dec 14;10(48):9944-9967. doi: 10.1039/d2tb01741e. J Mater Chem B. 2022. PMID: 36415922 Review.

6

Targeted Liposomal Co-delivery of an Immunogenic Cell Death Inducer and a Toll-Like Receptor 4 Agonist for Enhanced Cancer Chemo-immunotherapy.

Park H, Lee S, Son MK, Kang I, Surwase SS, Song YG, Lee HK, Lee YK, Kim YC. Park H, et al. Among authors: kim yc. ACS Appl Mater Interfaces. 2024 Aug 14;16(32):41810-41818. doi: 10.1021/acsami.4c04891. Epub 2024 Jul 31. ACS Appl Mater Interfaces. 2024. PMID: 39084852

7

Hybrid Nanoparticles of Extracellular Vesicles and Gemcitabine Prodrug-Loaded Liposomes with Enhanced Targeting Ability for Effective PDAC Treatment.

Kim B, Park H, Liu H, Kim S, Lee YK, Kim YC. Kim B, et al. Among authors: kim s, kim yc. ACS Appl Bio Mater. 2024 Sep 16;7(9):6025-6033. doi: 10.1021/acsabm.4c00658. Epub 2024 Sep 4. ACS Appl Bio Mater. 2024. PMID: 39231306

8

Liposomal Codelivery of Doxorubicin and Curcumin Sensitizes Antitumor Activity and Reduces Tumor Metastasis.

Kim S, Park H, Hong HJ, Lee S, Kim S, Lee YK, Shong M, Kim YC. Kim S, et al. Among authors: kim yc. ACS Appl Bio Mater. 2024 Dec 16;7(12):8367-8376. doi: 10.1021/acsabm.4c01146. Epub 2024 Nov 26. ACS Appl Bio Mater. 2024. PMID: 39591430

9

A core-shell microneedle system for stable fibroblast delivery in cell-based therapies.

Medico F, Kim S, Surwase SS, Liu H, Kim YC. Medico F, et al. Among authors: kim yc. Drug Deliv Transl Res. 2024 Dec 19. doi: 10.1007/s13346-024-01759-8. Online ahead of print. Drug Deliv Transl Res. 2024. PMID: 39699751

10

Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.

Yoo J, Lee D, Gujrati V, Rejinold NS, Lekshmi KM, Uthaman S, Jeong C, Park IK, Jon S, Kim YC. Yoo J, et al. Among authors: kim yc. J Control Release. 2017 Jan 28;246:142-154. doi: 10.1016/j.jconrel.2016.04.040. Epub 2016 May 8. J Control Release. 2017. PMID: 27170226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,307 results

Search Page

Filters